| Field | Sense | Antisense |
| siRNA chemical modification | DeoxyThymidine | DeoxyThymidine |
| siRNA modification types | 1 | 1 |
| Overall number of modifications | 2 | 2 |
| Position of modifications | 20,21 | 20,21 |
| Modification on sugar or base or phosphate | Sugar | Sugar |
| SMILES (Click to view structure & nomenclature) |
CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1=O |
CC1=CN(C2CC(O)C(CO)O2)C(=O)NC1=O |
| siRNA Sequence | GUAUCUCUUCAUAGCCUUATT | UAAGGCUAUGAAGAGAUACTT |
| siRNA length base-pair | 21 | 21 |
| siRNA name in paper | siNTCtrl | siNTCtrl |
| Biological activity | NA | |
| Experiment used to check activity | Quantitative PCR analysis | |
| Melting temperature (oC) | N.D. | |
| Target gene | apoB gene | |
| siRNA concentration | 10nM/L | |
| Cell or Organism used | NMuLi cells | |
| Transfection method | Lipofectamine RNAiMAX | |
| Duration after transfection | NA | |
| Article title | Development of a 2',4'-BNA/LNA-based siRNA for Dyslipidemia and Assessment of the Effects of Its Chemical Modifications In Vivo |
|
| Reference | 23344237 | |